“The PROTECT1 in 2009 was a feasibility study. The PROTECT2…” — Maryland CC Project at 19:44
“The PROTECT1 in 2009 was a feasibility study. The PROTECT2 in 2012 demonstrated no difference in mortality between CP, impella, and balloon pump at 30 or 90 days. PROTECT3 results, which just came out recently, demonstrated improved revascularization and less major adverse cardiac events with impella CP or 2.5 versus…”
0:00
24:43